Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.20
+0.20 (1.11%)
At close: Jun 26, 2026, 4:00 PM EDT
17.84
-0.36 (-1.98%)
After-hours: Jun 26, 2026, 5:50 PM EDT
Avalo Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Avalo Therapeutics stock have an average target of 45.9, with a low estimate of 34 and a high estimate of 60. The average target predicts an increase of 152.20% from the current stock price of 18.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Avalo Therapeutics stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 11 | 11 | 12 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Initiates $35 | Buy | Initiates | $35 | +92.31% | Jun 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $36 → $39 | Buy | Maintains | $36 → $39 | +114.29% | May 15, 2026 |
| Wedbush | Wedbush | Buy Reiterates $40 → $34 | Buy | Reiterates | $40 → $34 | +86.81% | May 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $39 → $45 | Buy | Maintains | $39 → $45 | +147.25% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
from 59.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-2.62
from -5.84
EPS Next Year
-2.80
from -2.62
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.77 | -1.33 | |
| Avg | -2.62 | -2.80 | |
| Low | -3.53 | -4.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.